harmacare
Research Paper
Pharmacist Disciplinary Action: What Do Pharmacists Get in Trouble for?
Ai-Leng Foong-Reichert, Kelly A. Grindrod, David J. Edwards, Zubin Austin and Sherilyn K.D. Houle
ICES Report
The Impact of Sex and Gender on Prescribing Cascades in Older Adults
Paula Rochon, Misty Pratt and Razan Rawdat
CIHI Survey
Overuse of Tests and Treatments: Has Canada Made Progress?
Alicia Costante, Xi-Kuan Chen, Alexey Dudevich, Antony Dennis Christy, Lyricy Francis and Cheryl Chu...
Invited Paper
Expensive Drugs for Rare Diseases in Canada: What Value and At What Cost?
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Larry D. Lynd, Eric Lun, Bob Nakagawa, Dean Regier, Shi...
Commentary
Specific, Fair and Transparent: A Canadian Process for Funding Drugs for Rare Diseases
Helen Stevenson
Commentary
What Procedural Ethics Can Learn from the Quest for Moral Justification for the “Rule of Rescue”
Bernard Keating
Commentary
Expensive Drug Prices for Rare Cancers: Are Patients Truly Benefitting?
Kristina Jenei and Bishal Gyawali